{"schema_version":"secwatch.filing_event.v1","accession":"0001601485-26-000058","form_type":"8-K","ticker":"ELTX","cik":"0001601485","company_name":"Elicio Therapeutics, Inc.","filed_at":"2026-09-14T20:03:29+00:00","discovered_at":"2026-09-14T20:05:00.267979+00:00","generated_at":"2026-09-14T20:05:05.787710+00:00","sec_items":["5.08","8.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Elicio sets 2026 annual meeting for Nov 12; shareholder proposals due Sept 24","bullets":["Annual meeting of stockholders scheduled for November 12, 2026.","Rule 14a-8 shareholder proposals must be received by September 24, 2026.","Director nominations and other bylaw proposals also due by September 24, 2026.","Proxy statement will detail time, location, and items to be voted on."],"urls":{"canonical":"https://secwatch.observer/filing/0001601485-26-000058","json":"https://secwatch.observer/filing/0001601485-26-000058.json","markdown":"https://secwatch.observer/filing/0001601485-26-000058.md","text":"https://secwatch.observer/filing/0001601485-26-000058.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1601485/000160148526000058/0001601485-26-000058-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1601485/000160148526000058/eltx-20260914.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-09-14T20:05:05.787710+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}